BELMAC CORP /FL/
NT 10-Q, 1995-11-15
PHARMACEUTICAL PREPARATIONS
Previous: INNOVET INC, 10QSB, 1995-11-15
Next: WELLS REAL ESTATE FUND II-OW, 10-Q, 1995-11-15




<PAGE>

                           UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION           SEC FILE NUMBER
                      Washington, D.C. 20549                  1-10581

                            FORM 12b-25                      CUSIP NUMBER
                                                              080055-20-5
                    NOTIFICATION OF LATE FILING

(Check One):[ ]Form 10-K [ ]Form 20-F [ ]Form 11-K [X]Form 10-Q [ ]Form N-SAR

           For Period Ended:       September 30, 1995              
        
           [   ] Transition Report on Form 10-K
           [   ] Transition Report on Form 20-F
           [   ] Transition Report on Form 11-K
           [   ] Transition Report on Form 10-Q
           [   ] Transition Report on Form N-SAR
           For the Transition Period Ended:                       

- -------------------------------------------------------------------------------
  Read Instruction (on back page) Before Preparing Form.  Please
                          Print or Type.
     Nothing in this form shall be construed to imply that the
     Commission has verified any information contained herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify 
the Item(s) to which the notification relates:


PART I   REGISTRANT INFORMATION

Belmac Corporation                        
- -----------------------------------------------------------
Full Name of Registrant


- -----------------------------------------------------------
Former Name if Applicable


4830 West Kennedy Boulevard, One Urban Centre, Suite 550          
- -----------------------------------------------------------
Address of Principal Executive Office (Street and Number)


Tampa, Florida  33609
- -----------------------------------------------------------
City, State and Zip Code

PART II   RULES 12b-25(b) AND (c)

If  the  subject  report  could  not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b),  the  following  should  be  completed.  (Check  box if
appropriate)

      a. The reasons described in reasonable detail in Part III of
         this form  could  not  be  eliminated  without unreasonable
         effort or expense;
      b. The   subject   annual   report,   semi-annual   report,
         transition  report on Form 10-K, Form 20-F, 11-K or Form
[ X ]    N-SAR,  or  portion  thereof, will be filed on or before
         the  fifteenth calendar day following the prescribed due
         date;  or  the  subject  quarterly  report of transition
         report on Form 10-Q, or portion thereof will be filed on
         or   before  the  fifth  calendar  day  following  the
         prescribed due date; and
      c. The  accountant's statement or other exhibit required by
         Rule 12-b-25(c) has been attached if applicable.

PART III   NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F,
11-K,  10-Q,  N-SAR,  or the transition report or portion thereof,
could not be filed within the prescribed time period.

                        SEE ATTACHED SHEET

                                             (Attach Extra Sheets if Needed)
</PAGE>   <PAGE>

<PAGE>

 PART IV   OTHER INFORMATION

(1)  Name and telephone number of person to contact in regard to this
     notification
   
        Michael D. Price               813                  286-4401
       ------------------             -----             ----------------
             (Name)                   (Area             (Telephone Number)
      Vice President and Chief         Code)
            Financial Officer


(2)  Have all other periodic reports required under Section
     13  or 15(d) of the Securities Exchange Act of 1934 or
     Section  30  of  the  Investment  Company  Act of 1940   X  Yes     No
     during  the  preceding  12  months or for such shorter  ---    ---
     period  that  the registrant was required to file such
     report(s)  been  filed?    If  answer  is no, identify
     report(s)


(3)  Is  it  anticipated  that  any  significant  change in
     results  of  operations  from the corresponding period     Yes    X  No
     for  the  last  fiscal  year  will be reflected by the  ---      ---
     earnings  statements  to  be  included  in the subject
     report or portion thereof?

     If so, attach an explanation of the anticipated change, both
     narratively and quantitatively, and, if appropriate, state the
     reasons why a reasonable estimate of results cannot be made.
==============================================================================


                            Belmac Corporation
                --------------------------------------------
                (Name of Registrant as Specified in Charter)

 has caused this notification to be signed on its behalf by the undersigned
 hereunto duly authorized.





 Date  November 15, 1995               By   /s/ Michael D. Price        
                                         Michael D. Price, Vice President
                                         and Chief Financial Officer







</PAGE> <PAGE>

<PAGE>

            Notification of Late Filing on Form 12b-25


                    Registrant:    Belmac Corporation

                    Report:        Report on Form 10-Q for the
                                   Quarter ended September 30, 1995


Part III - Narrative

   Each  of  the  two  wholly-owned  foreign  subsidiaries  of the
Registrant,  both  of  which  represent material components in the
consolidated  financial  statements, has experienced delays in the
production  of  financial  data  necessary  for  the Registrant to
complete  its  quarterly report on Form 10-Q for the quarter ended
September 30, 1995 without unreasonable effort or expense. 







</PAGE> <PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission